Monday, November 10, 2008

DrEddy Blog - Stories and opinion about health, illness and medicine

The patients receiving the drug, Crestor (rosuvastatin), did have high levels of C-reactive protein (CRP), a marker for the inflammation process which is implicated in hardening of the arteries. The study, sponsored by drug maker ...Read More

No comments: